The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection.
Open accessAbstract
The serious shortage of human organs available for transplantation has engendered a heightened interest in the use of animal organs (xenografts) for transplantation. However, the major barrier to successful discordant xenogeneic organ transplantation is the phenomenon of hyperacute rejection. Hyperacute rejection results from the deposition of high-titer preformed antibodies that activate serum complement on the luminal surface of the vascular endothelium, leading to vessel occlusion and graft failure within minutes to hours. Although endogenous membrane-associated complement inhibitors normally protect endothelial cells from autologous complement, they are species restricted and thus confer limited resistance to activated xenogeneic complement. To address the pathogenesis of hyperacute rejection in xenotransplantation, transgenic mice and a transgenic pig were engineered to express the human terminal complement inhibitor hCD59. High-level cell surface expression of hCD59 was achieved in a variety of murine and porcine cell types, most importantly on both large vessel and capillary endothelium. hCD59-expressing porcine cells were significantly resistant to challenge with high-titer anti-porcine antibody and human complement. These experiments demonstrate a strategy for developing a pig-to-primate xenogeneic transplantation model to test whether the expression of a human complement inhibitor in transgenic pigs could render xenogeneic organs resistant to hyperacute rejection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Church, G. M., & Gilbert, W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.7.1991 · Cited by 8,116
Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes.
Sandrin, M. S., Vaughan, H. A., Dabkowski, P. L., & McKenzie, I. F. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11391 · Cited by 605
Transplantation of discordant xenografts: a review of progress
Platt, J. L., Vercellotti, G. M., Dalmasso, A. P., Matas, A. J., Bolman, R. M., Najarian, J. S., & Bach, F. H. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90174-8 · Cited by 536
Kimura, A., Israël, A., Le Bail, O., & Kourilsky, P. (1986) · Cell · doi:10.1016/0092-8674(86)90760-9 · Cited by 368
Larsen, R. D., Rivera-Marrero, C. A., Ernst, L. K., Cummings, R. D., & Lowe, J. B. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39258-0 · Cited by 284
Weiss, E., Golden, L., Zakut, R., Mellor, A., Fahrner, K., Kvist, S., & Flavell, R. A. (1983) · The EMBO Journal · doi:10.1002/j.1460-2075.1983.tb01444.x · Cited by 274
DALMASSO, A. P., VERCELLOTTI, G. M., PLATT, J. L., & BACH, F. H. (1991) · Transplantation · doi:10.1097/00007890-199109000-00029 · Cited by 264
THE EFFECT OF SOLUBLE COMPLEMENT RECEPTOR TYPE 1 ON HYPERACUTE REJECTION OF PORCINE XENOGRAFTS
Pruitt, S. K., Kirk, A. D., Bollinger, R. R., Marsh, H. C., Collins, B. H., Levin, J. L., Mault, J. R., Heinle, J. S., Ibrahim, S., Rudolph, A. R., et al. (1994) · Transplantation · doi:10.1097/00007890-199402150-00009 · Cited by 262
Dalmasso, A. P., Vercellotti, G. M., Fischel, R. J., Bolman, R. M., III, Bach, F. H., & Platt, J. L. (1992) · PubMed Central · Cited by 250
Rollins, S. A., Zhao, J., Ninomiya, H., & Sims, P. J. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.7.2345 · Cited by 206
Self-citationThe collagenous components of the subendothelium. Correlation of structure and function.
Madri, J. A., Dreyer, B., Pitlick, F. A., & Furthmayr, H. (1980) · PubMed · Cited by 201
Self-citationENDOTHELIAL CELL ANTIGENS RECOGNIZED BY XENOREACTIVE HUMAN NATURAL ANTIBODIES
PLATT, J. L., LINDMAN, B. J., CHEN, H., SPITALNIK, S. L., & BACH, F. H. (1990) · Transplantation · doi:10.1097/00007890-199011000-00015 · Cited by 167
Johnson, D. R., & Pober, J. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5183 · Cited by 104
Blanar, M. A., Baldwin, A. S., Flavell, R. A., & Sharp, P. A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03484.x · Cited by 103
Wing, M. G., Zajicek, J., Seilly, D. J., Compston, D. A. S., & Lachmann, P. J. (1992) · PubMed Central · Cited by 52
In vivo induction of H‐2K/D antigens by recombinant interferon‐γ
Momburg, F., Koch, N., Möller, P., Moldenhauer, G., & Hämmerling, G. J. (1986) · European Journal of Immunology · doi:10.1002/eji.1830160516 · Cited by 40
Cited by
Infection of human cells by an endogenous retrovirus of pigs
Patience, C., Takeuchi, Y., & Weiss, R. A. (1997) · Nature Medicine · doi:10.1038/nm0397-282 · Cited by 953
The generation of transgenic pigs as potential organ donors for humans
Cozzi, E., & White, D. J. G. (1995) · Nature Medicine · doi:10.1038/nm0995-964 · Cited by 602
Clinical xenotransplantation: the next medical revolution?
Ekser, B., Ezzelarab, M., Hara, H., van der Windt, D. J., Wijkstrom, M., Bottino, R., Trucco, M., & Cooper, D. K. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61091-x · Cited by 353
Membrane complement regulatory proteins
Kim, D. D., & Song, W.-C. (2006) · Clinical Immunology · doi:10.1016/j.clim.2005.10.014 · Cited by 353
Genetically enhanced cows resist intramammary Staphylococcus aureus infection
Wall, R. J., Powell, A. M., Paape, M. J., Kerr, D. E., Bannerman, D. D., Pursel, V. G., Wells, K. D., Talbot, N., & Hawk, H. W. (2005) · Nature Biotechnology · doi:10.1038/nbt1078 · Cited by 343
Metadata
- Authors
- Fodor, W. L., Williams, B. L., Matis, L. A., Madri, J. A., Rollins, S. A., Knight, J. W., Velander, W., & Squinto, S. P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1994-11-08
- Volume
- 91
- Issue
- 23
- Pages
- 11153-11157
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2059171126
- Cited by
- 344
- References
- 16
- FWCI
- 31.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.